Biovisc

By Biotech Healthcare Holding (Switzerland)

Biovisc by Biotech Healthcare Holding, Switzerland, is a premium range of hyaluronic acid-based formulations designed to improve joint health and mobility. Developed using bacterial fermentation, these high molecular weight sodium hyaluronate solutions are tailored to meet diverse clinical needs.

Biovisc Ortho and Biovisc Ortho M are ideal for multi-injection protocols with weekly intervals, providing sustained relief. Biovisc Ortho Plus offers a higher concentration, delivering enhanced viscosity and performance for more intensive care. For long-lasting joint support, Biovisc Ortho Single 60 and Biovisc Ortho Single 90 feature cross-linked hyaluronic acid in a convenient single-injection format. This versatile range ensures effective and targeted care for patients seeking improved joint function and comfort.

select other brand

Ejal Synocrom Seventy Hyal 2000 RenehaVis Pluryal Plenhyage Olidia MONALISA HYAMINO Linerase INFINI iLLUMA HYALGAN CG DiMONO PTx EUFLEXXA EMLA DR.PEEL DIVES DEHYAL+ Curavisc Biovisc AESTHEFILL AESPLLA RRS Skinfill Ialest ReNTox Neotox Zerotox Bienox Hutox Kamomis METOX Letybo Botulax Coretox Neuronox Innotox Nabota Newest Plinest Rich PL SAYPHA CINGAL DERMAHEAL Croma KYBELLA BELOTERO AQUASHINE ALIDYA ALIAXIN AESSOA Lemon Bottle Stylage Supartz Fx Synvisc Teosyal Cytocare Dr cyj hair filler Durolane Ejal40 Ellanse Fillmed GOURI HArmonyCa HYAcorp Jalupro Juvederm Karisma Mesoestetic Neauvia Nithya Nucleofill Orthovisc Perfectha Profhilo Radiesse Restylane Revolax Sculptra

Biovisc Ortho

Syringe 1 x 2mL
Hyaluronic Acid 20mg/2mL (1%)

Biovisc Ortho is a 1% Sodium Hyaluronate (20 mg) solution, derived from bacterial fermentation for superior purity. Each 2 mL injection supports joint lubrication and mobility, recommended as a 3–5 injection regimen with weekly intervals. With a molecular weight of 2.8–3.2 million daltons, an osmolality of 270–400 mOsm/kg, and a viscosity of 300,000–450,000 mPa·s at 25°C, it ensures excellent viscoelastic properties for effective joint care.

Biovisc Ortho M

Syringe 1 x 2mL
Hyaluronic Acid 40 mg/2ml (2%)
Mannitol 10mg/2ml (0.5 %)

Biovisc Ortho M is a 2 mL syringe containing 2% Hyaluronic Acid (40 mg) combined with 0.5% Mannitol (10 mg). This advanced formulation provides enhanced joint lubrication and protection, with Mannitol acting as an antioxidant to stabilize the hyaluronic acid and prolong its effectiveness. Designed for optimal joint health, it offers superior viscoelastic properties and long-lasting relief for improved mobility and comfort.

Biovisc Ortho Plus

Syringe 1 x 2mL
Hyaluronic Acid 40mg/2ml (2%)

Biovisc Ortho Plus contains 2% Sodium Hyaluronate (40 mg), offering enhanced viscosity for advanced joint support. Derived from bacterial fermentation, each 2 mL injection is part of a 3–5 injection weekly regimen. It features a molecular weight of 2.8–3.2 million daltons, an osmolality of 270–400 mOsm/kg, and a viscosity of 400,000–700,000 mPa·s at 25°C, making it ideal for intensive joint care.

Biovisc Ortho Single 90

Syringe 1 x 3mL
Crosslinked HA 90mg/3ml (3%)

Biovisc Ortho Single 90 delivers 3% cross-linked Sodium Hyaluronate (90 mg) in a 3 mL single-injection format for long-lasting joint relief. Produced through bacterial fermentation, it has a molecular weight of 2.8–3.2 million daltons, an osmolality of 270–400 mOsm/kg, and a viscosity of 500,000–850,000 mPa·s at 25°C, ensuring exceptional cushioning and durability.

IS YOUR PRODUCT MISSING FROM OUR RANGE?

Get in touch to hear more about how to become a supplier.

WeChat ID: Bioresus